🔎 Trials Near Me

Akèy › Artrit Rematoid › Ohio

Etid klinik pou Artrit Rematoid nan Ohio

7 etid pou Artrit Rematoid ap chèche patisipan nan sit nan Ohio.

Vil nan Ohio

Tèks ofisyèl etid la (Anglè)

RA-PRO PRAGMATIC TRIAL

  • University Hospital Cleveland Medical Ctr, Cleveland
  • The MetroHealth System, Cleveland
  • Arthritis and Rheumatology of Southwest Ohio, Liberty Township
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT04692493

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Ohio State University Comprehensive Cancer Center, Columbus
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

  • Paramount Medical Research and Consulting /ID# 272474, Middleburg Heights
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06972446

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

  • Ohio State University Wexner Medical Center, Columbus
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07137598

Exactech Shoulder Post Market Clinical Follow-up Study

  • Crystal Clinic Orthopaedic, Akron
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT05603728

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  • MetroHealth Medical Center, Cleveland
  • The Metro Health System Main Campus, Cleveland
  • Cleveland Clinic Foundation, Cleveland
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 21, 2026 · NCT06570798

IMPACT - AndHealth Autoimmune Research Registry

  • AndHealth, Columbus
Ap rekriteEtid obsèvasyon
Laj 18 a 70 · Tout sèks · Mizajou Jun 29, 2023 · NCT05883371

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.